2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Most active institutional investors by number of deals

Investor Profile Country Deals
Kleiner Perkins Caufield & Byers LLC Venture capital firm. United States 20
MPM Asset Management LLC United States 20
Pappas Ventures United States 20
Polaris Venture Partners Inc Multistage venture capital investors with focus Technology, Healthcare and Consumer United States 20
Johnson & Johnson Development Corp Inc United States 19
Sutter Hill Ventures United States 19
BioAdvance - Biotechnology Greenhouse Corporation of Southeastern Pennsylvania United States 18
Delphi Ventures Inc Venture capital firm with a focus on early stage investing in medical devices and biotechnology United States 18
Flagship Ventures Venture capital firm United States 18
Quaker BioVentures Inc United States 18
Novartis Venture Funds The corporate venturing arm of Novartis. Switzerland 17
Thomas McNerney & Partners LLC Healthcare venture firm. United States 17
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies United States 16
Clarus Ventures LLC Life sciences venture capital firm United States 16
HBM BioVentures AG Switzerland 16
Montreux Equity Partners United States 16
NGN Capital United States 16
One Liberty Ventures United States 16
ProQuest Investments United States 16
Prospect Venture Partners Venture capital firm United States 16

Pages

Selected funding rounds

Date Company Profile Round Ccy Amount
Jul 2012 Juventas Therapeutics Inc Series B
Jul 2012 Juventas Therapeutics Inc Series B
Jul 2012 Juventas Therapeutics Inc Series B
18 Jun 2012 Oxford Immunotec Ltd Venture USD 28,000,000
Jun 2012 Gemmus Pharma Inc Developer of innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases. Series A
Jun 2012 InnoPharma LLC N/A
Jun 2012 InnoPharma LLC N/A
Jun 2012 Auxogyn Inc Series B
Jun 2012 Santaris Pharma AS Venture
Jun 2012 Santaris Pharma AS Venture
Jun 2012 Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. Debt
Jun 2012 Ceptaris Therapeutics Inc Specialty pharmaceuticals company. Series D
Jun 2012 Santaris Pharma AS Venture
Jun 2012 Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. Debt
Jun 2012 Santaris Pharma AS Venture
Jun 2012 Santaris Pharma AS Venture
May 2012 AssureRx Health Inc Personalized medicine company specializing in pharmacogenetics Series C
May 2012 Zurex Pharma Inc N/A
May 2012 Zurex Pharma Inc Series A
Apr 2012 ALDEA Pharmaceuticals N/A

Pages

Selected acquisitions

Date Company Profile Country Ccy Amount
12 Jul 1999 Perclose Inc United States
14 Apr 1998 VacTex Inc
24 Feb 1998 Somatogen Inc A biopharmaceutical company developing synthetic hemoglobin products for use in blood transfusion. United States
Inpharmatica Ltd United Kingdom
Memory Pharmaceuticals Corp United States

Pages

Selected companies

Company type: 
Pharmaceutical company focused on the development and commercialization of proprietary oral sorbent technology.
Company type: 
Specialty pharmaceutical company, focused on pediatric neurology.
Company type: 
Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue
Company type: 
AEGEA Medical, Inc. develops and sells medical devices for treatment of abnormal uterine bleeding.
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products